Sign inJoin waitlistJoin the waitlist

Camilo Jimenez

Professor · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present

Endocrinology, Diabetes, and Metabolism
1999–2001
Internal Medicine
University of Miami/Jackson Health System
1998–1999
National Cancer Institute
1996–1998
Doctor of Medicine
1991–1995

Research

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as…
The Journal of Clinical Endocrinology & Metabolism · 2011 · Last of 13 authors · 348 citations
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Review · Endocrine Reviews · 2019 · Last of 3 authors · 277 citations
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Journal of Nuclear Medicine · 2019 · Last of 19 authors · 235 citations

MH
Mouhammad Habra
50 papers
Steven Waguespack
47 papers
Nancy Perrier
38 papers
Elizabeth Grubbs
25 papers · 3 as a fellow
Naifa Busaidy
24 papers · 1 as a fellow
Mimi Hu
23 papers · 2 as a fellow
Jeena Varghese
22 papers · 3 as a fellow
Jeffrey Lee
19 papers
RG
Robert Gagel
19 papers
Maria Cabanillas
17 papers · 1 as a fellow
RV
Rena Vassilopoulou-Sellin
13 papers
Steven Sherman
13 papers

Clinical trials

Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2019–2020
Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2015–2024